Engages in the developing and manufacturing of monoclonal antibody therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, CDMO has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CDMO jumps, then AXON could also see price increases.
Ticker / NAME | Correlation To CDMO | 1D Price Change % | ||
---|---|---|---|---|
CDMO | 100% | +0.41% | ||
AXON - CDMO | 49% Loosely correlated | +0.90% | ||
DRMA - CDMO | 42% Loosely correlated | -1.12% | ||
ARRY - CDMO | 41% Loosely correlated | +4.74% | ||
BEAM - CDMO | 40% Loosely correlated | +6.23% | ||
CRSP - CDMO | 38% Loosely correlated | +3.43% | ||
More |